APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albendazole Anthelmintic Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Albendazole Anthelmintic Drug Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchAlbendazole Anthelmintic Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Albendazole Anthelmintic Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Albendazole Anthelmintic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albendazole Anthelmintic Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Albendazole Anthelmintic Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Albendazole Anthelmintic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Albendazole Anthelmintic Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Albendazole Anthelmintic Drug market include Jiangsu Qihui, Huazhong Pharmaceutical, GlaxoSmithKline, Zhongjia Pharmaceutical, Supharma Chem, Sequent Scientific, Salius Pharma, Lasa Supergenerics Limited and K.A. Malle Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Albendazole Anthelmintic Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Albendazole Anthelmintic Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Albendazole Anthelmintic Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albendazole Anthelmintic Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Albendazole Anthelmintic Drug Segment by Company

Jiangsu Qihui

Huazhong Pharmaceutical

GlaxoSmithKline

Zhongjia Pharmaceutical

Supharma Chem

Sequent Scientific

Salius Pharma

Lasa Supergenerics Limited

K.A. Malle Pharmaceuticals

Fredun Pharmaceuticals Ltd

Albendazole Anthelmintic Drug Segment by Type

Tablet

Capsule

Other

Albendazole Anthelmintic Drug Segment by Application

Human

Veterinary

Albendazole Anthelmintic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Albendazole Anthelmintic Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Albendazole Anthelmintic Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Albendazole Anthelmintic Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Albendazole Anthelmintic Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole Anthelmintic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albendazole Anthelmintic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole Anthelmintic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Albendazole Anthelmintic Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Albendazole Anthelmintic Drug industry.

Chapter 3: Detailed analysis of Albendazole Anthelmintic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Albendazole Anthelmintic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Albendazole Anthelmintic Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Albendazole Anthelmintic Drug Industry Trends Table 2. Albendazole Anthelmintic Drug Industry Drivers Table 3. Albendazole Anthelmintic Drug Industry Opportunities and Challenges Table 4. Albendazole Anthelmintic Drug Industry Restraints Table 5. Global Albendazole Anthelmintic Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Albendazole Anthelmintic Drug Revenue Share by Company (2021-2026) Table 7. Global Albendazole Anthelmintic Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Albendazole Anthelmintic Drug Sales Volume Share by Company (2021-2026) Table 9. Global Albendazole Anthelmintic Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Albendazole Anthelmintic Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Albendazole Anthelmintic Drug Key Company Manufacturing Base & Headquarters Table 12. Global Albendazole Anthelmintic Drug Company, Product Type & Application Table 13. Global Albendazole Anthelmintic Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Albendazole Anthelmintic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Capsule Table 19. Significant Companies of Other Table 20. Global Albendazole Anthelmintic Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Albendazole Anthelmintic Drug Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Albendazole Anthelmintic Drug Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Albendazole Anthelmintic Drug Sales Volume Share by Type (2021-2026) Table 24. Global Albendazole Anthelmintic Drug Sales Volume Share by Type (2027-2032) Table 25. Global Albendazole Anthelmintic Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Albendazole Anthelmintic Drug Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Albendazole Anthelmintic Drug Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Albendazole Anthelmintic Drug Sales Value Share by Type (2021-2026) Table 29. Global Albendazole Anthelmintic Drug Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Human Table 31. Significant Companies of Veterinary Table 32. Global Albendazole Anthelmintic Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Albendazole Anthelmintic Drug Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Albendazole Anthelmintic Drug Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Albendazole Anthelmintic Drug Sales Volume Share by Application (2021-2026) Table 36. Global Albendazole Anthelmintic Drug Sales Volume Share by Application (2027-2032) Table 37. Global Albendazole Anthelmintic Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Albendazole Anthelmintic Drug Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Albendazole Anthelmintic Drug Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Albendazole Anthelmintic Drug Sales Value Share by Application (2021-2026) Table 41. Global Albendazole Anthelmintic Drug Sales Value Share by Application (2027-2032) Table 42. Global Albendazole Anthelmintic Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Albendazole Anthelmintic Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2021-2026) Table 45. Global Albendazole Anthelmintic Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Albendazole Anthelmintic Drug Sales Market Share by Region (2027-2032) Table 47. Global Albendazole Anthelmintic Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Albendazole Anthelmintic Drug Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Albendazole Anthelmintic Drug Sales Value Share by Region (2021-2026) Table 50. Global Albendazole Anthelmintic Drug Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Albendazole Anthelmintic Drug Sales Value Share by Region (2027-2032) Table 52. Global Albendazole Anthelmintic Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Albendazole Anthelmintic Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Albendazole Anthelmintic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Albendazole Anthelmintic Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 57. Global Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2026) Table 58. Global Albendazole Anthelmintic Drug Sales by Country (2027-2032) & (K Units) Table 59. Global Albendazole Anthelmintic Drug Sales Market Share by Country (2027-2032) Table 60. Global Albendazole Anthelmintic Drug Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Albendazole Anthelmintic Drug Sales Value Market Share by Country (2021-2026) Table 62. Global Albendazole Anthelmintic Drug Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Albendazole Anthelmintic Drug Sales Value Market Share by Country (2027-2032) Table 64. Jiangsu Qihui Company Information Table 65. Jiangsu Qihui Business Overview Table 66. Jiangsu Qihui Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Jiangsu Qihui Albendazole Anthelmintic Drug Product Portfolio Table 68. Jiangsu Qihui Recent Development Table 69. Huazhong Pharmaceutical Company Information Table 70. Huazhong Pharmaceutical Business Overview Table 71. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio Table 73. Huazhong Pharmaceutical Recent Development Table 74. GlaxoSmithKline Company Information Table 75. GlaxoSmithKline Business Overview Table 76. GlaxoSmithKline Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GlaxoSmithKline Albendazole Anthelmintic Drug Product Portfolio Table 78. GlaxoSmithKline Recent Development Table 79. Zhongjia Pharmaceutical Company Information Table 80. Zhongjia Pharmaceutical Business Overview Table 81. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio Table 83. Zhongjia Pharmaceutical Recent Development Table 84. Supharma Chem Company Information Table 85. Supharma Chem Business Overview Table 86. Supharma Chem Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Supharma Chem Albendazole Anthelmintic Drug Product Portfolio Table 88. Supharma Chem Recent Development Table 89. Sequent Scientific Company Information Table 90. Sequent Scientific Business Overview Table 91. Sequent Scientific Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sequent Scientific Albendazole Anthelmintic Drug Product Portfolio Table 93. Sequent Scientific Recent Development Table 94. Salius Pharma Company Information Table 95. Salius Pharma Business Overview Table 96. Salius Pharma Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Salius Pharma Albendazole Anthelmintic Drug Product Portfolio Table 98. Salius Pharma Recent Development Table 99. Lasa Supergenerics Limited Company Information Table 100. Lasa Supergenerics Limited Business Overview Table 101. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Portfolio Table 103. Lasa Supergenerics Limited Recent Development Table 104. K.A. Malle Pharmaceuticals Company Information Table 105. K.A. Malle Pharmaceuticals Business Overview Table 106. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Portfolio Table 108. K.A. Malle Pharmaceuticals Recent Development Table 109. Fredun Pharmaceuticals Ltd Company Information Table 110. Fredun Pharmaceuticals Ltd Business Overview Table 111. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Portfolio Table 113. Fredun Pharmaceuticals Ltd Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Albendazole Anthelmintic Drug Distributors List Table 117. Albendazole Anthelmintic Drug Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Albendazole Anthelmintic Drug Product Image Figure 2. Global Albendazole Anthelmintic Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albendazole Anthelmintic Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Albendazole Anthelmintic Drug Sales (2021-2032) & (K Units) Figure 5. Global Albendazole Anthelmintic Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Albendazole Anthelmintic Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Capsule Image Figure 11. Other Image Figure 12. Global Albendazole Anthelmintic Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Albendazole Anthelmintic Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Albendazole Anthelmintic Drug Sales Volume Share by Type (2021-2032) Figure 15. Global Albendazole Anthelmintic Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Albendazole Anthelmintic Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Albendazole Anthelmintic Drug Sales Value Share by Type (2021-2032) Figure 18. Human Image Figure 19. Veterinary Image Figure 20. Global Albendazole Anthelmintic Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Albendazole Anthelmintic Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Albendazole Anthelmintic Drug Sales Volume Share by Application (2021-2032) Figure 23. Global Albendazole Anthelmintic Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Albendazole Anthelmintic Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Albendazole Anthelmintic Drug Sales Value Share by Application (2021-2032) Figure 26. Global Albendazole Anthelmintic Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Albendazole Anthelmintic Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Albendazole Anthelmintic Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Albendazole Anthelmintic Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Albendazole Anthelmintic Drug Sales Value (2021-2032) & (US$ Million) Figure 31. North America Albendazole Anthelmintic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Albendazole Anthelmintic Drug Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Albendazole Anthelmintic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Albendazole Anthelmintic Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Albendazole Anthelmintic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Albendazole Anthelmintic Drug Sales Value (2021-2032) & (US$ Million) Figure 37. South America Albendazole Anthelmintic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Albendazole Anthelmintic Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Albendazole Anthelmintic Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Albendazole Anthelmintic Drug Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Albendazole Anthelmintic Drug Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Human
  • Veterinary
Companies covered
  • Jiangsu Qihui
  • Huazhong Pharmaceutical
  • GlaxoSmithKline
  • Zhongjia Pharmaceutical
  • Supharma Chem
  • Sequent Scientific
  • Salius Pharma
  • Lasa Supergenerics Limited
  • K.A. Malle Pharmaceuticals
  • Fredun Pharmaceuticals Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Albendazole Anthelmintic Drug Sales Value (2021-2032)
  4. 1.2.2 Global Albendazole Anthelmintic Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Albendazole Anthelmintic Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Albendazole Anthelmintic Drug Market Dynamics
  1. 2.1 Albendazole Anthelmintic Drug Industry Trends
  2. 2.2 Albendazole Anthelmintic Drug Industry Drivers
  3. 2.3 Albendazole Anthelmintic Drug Industry Opportunities and Challenges
  4. 2.4 Albendazole Anthelmintic Drug Industry Restraints
3 Albendazole Anthelmintic Drug Market by Company
  1. 3.1 Global Albendazole Anthelmintic Drug Company Revenue Ranking in 2025
  2. 3.2 Global Albendazole Anthelmintic Drug Revenue by Company (2021-2026)
  3. 3.3 Global Albendazole Anthelmintic Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Albendazole Anthelmintic Drug Average Price by Company (2021-2026)
  5. 3.5 Global Albendazole Anthelmintic Drug Company Ranking (2024-2026)
  6. 3.6 Global Albendazole Anthelmintic Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Albendazole Anthelmintic Drug Company Product Type and Application
  8. 3.8 Global Albendazole Anthelmintic Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Albendazole Anthelmintic Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Albendazole Anthelmintic Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Albendazole Anthelmintic Drug Market by Type
  1. 4.1 Albendazole Anthelmintic Drug Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.1.3 Other
  5. 4.2 Global Albendazole Anthelmintic Drug Sales Volume by Type
  6. 4.2.1 Global Albendazole Anthelmintic Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Albendazole Anthelmintic Drug Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Albendazole Anthelmintic Drug Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Albendazole Anthelmintic Drug Sales Value by Type
  10. 4.3.1 Global Albendazole Anthelmintic Drug Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Albendazole Anthelmintic Drug Sales Value by Type (2021-2032)
  12. 4.3.3 Global Albendazole Anthelmintic Drug Sales Value Share by Type (2021-2032)
5 Albendazole Anthelmintic Drug Market by Application
  1. 5.1 Albendazole Anthelmintic Drug Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Albendazole Anthelmintic Drug Sales Volume by Application
  5. 5.2.1 Global Albendazole Anthelmintic Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Albendazole Anthelmintic Drug Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Albendazole Anthelmintic Drug Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Albendazole Anthelmintic Drug Sales Value by Application
  9. 5.3.1 Global Albendazole Anthelmintic Drug Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Albendazole Anthelmintic Drug Sales Value by Application (2021-2032)
  11. 5.3.3 Global Albendazole Anthelmintic Drug Sales Value Share by Application (2021-2032)
6 Albendazole Anthelmintic Drug Regional Sales and Value Analysis
  1. 6.1 Global Albendazole Anthelmintic Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Albendazole Anthelmintic Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Albendazole Anthelmintic Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Albendazole Anthelmintic Drug Sales by Region (2027-2032)
  5. 6.3 Global Albendazole Anthelmintic Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Albendazole Anthelmintic Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Albendazole Anthelmintic Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Albendazole Anthelmintic Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Albendazole Anthelmintic Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Albendazole Anthelmintic Drug Sales Value (2021-2032)
  12. 6.6.2 North America Albendazole Anthelmintic Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Albendazole Anthelmintic Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Albendazole Anthelmintic Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Albendazole Anthelmintic Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Albendazole Anthelmintic Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Albendazole Anthelmintic Drug Sales Value (2021-2032)
  21. 6.9.2 South America Albendazole Anthelmintic Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Albendazole Anthelmintic Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Albendazole Anthelmintic Drug Sales Value Share by Country, 2025 VS 2032
7 Albendazole Anthelmintic Drug Country-level Sales and Value Analysis
  1. 7.1 Global Albendazole Anthelmintic Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Albendazole Anthelmintic Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Albendazole Anthelmintic Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Albendazole Anthelmintic Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Albendazole Anthelmintic Drug Sales by Country (2027-2032)
  6. 7.4 Global Albendazole Anthelmintic Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Albendazole Anthelmintic Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Albendazole Anthelmintic Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Albendazole Anthelmintic Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Albendazole Anthelmintic Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Albendazole Anthelmintic Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jiangsu Qihui
  2. 8.1.1 Jiangsu Qihui Company Information
  3. 8.1.2 Jiangsu Qihui Business Overview
  4. 8.1.3 Jiangsu Qihui Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jiangsu Qihui Albendazole Anthelmintic Drug Product Portfolio
  6. 8.1.5 Jiangsu Qihui Recent Developments
  7. 8.2 Huazhong Pharmaceutical
  8. 8.2.1 Huazhong Pharmaceutical Company Information
  9. 8.2.2 Huazhong Pharmaceutical Business Overview
  10. 8.2.3 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
  12. 8.2.5 Huazhong Pharmaceutical Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Albendazole Anthelmintic Drug Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Zhongjia Pharmaceutical
  20. 8.4.1 Zhongjia Pharmaceutical Company Information
  21. 8.4.2 Zhongjia Pharmaceutical Business Overview
  22. 8.4.3 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
  24. 8.4.5 Zhongjia Pharmaceutical Recent Developments
  25. 8.5 Supharma Chem
  26. 8.5.1 Supharma Chem Company Information
  27. 8.5.2 Supharma Chem Business Overview
  28. 8.5.3 Supharma Chem Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Supharma Chem Albendazole Anthelmintic Drug Product Portfolio
  30. 8.5.5 Supharma Chem Recent Developments
  31. 8.6 Sequent Scientific
  32. 8.6.1 Sequent Scientific Company Information
  33. 8.6.2 Sequent Scientific Business Overview
  34. 8.6.3 Sequent Scientific Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sequent Scientific Albendazole Anthelmintic Drug Product Portfolio
  36. 8.6.5 Sequent Scientific Recent Developments
  37. 8.7 Salius Pharma
  38. 8.7.1 Salius Pharma Company Information
  39. 8.7.2 Salius Pharma Business Overview
  40. 8.7.3 Salius Pharma Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Salius Pharma Albendazole Anthelmintic Drug Product Portfolio
  42. 8.7.5 Salius Pharma Recent Developments
  43. 8.8 Lasa Supergenerics Limited
  44. 8.8.1 Lasa Supergenerics Limited Company Information
  45. 8.8.2 Lasa Supergenerics Limited Business Overview
  46. 8.8.3 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Portfolio
  48. 8.8.5 Lasa Supergenerics Limited Recent Developments
  49. 8.9 K.A. Malle Pharmaceuticals
  50. 8.9.1 K.A. Malle Pharmaceuticals Company Information
  51. 8.9.2 K.A. Malle Pharmaceuticals Business Overview
  52. 8.9.3 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Portfolio
  54. 8.9.5 K.A. Malle Pharmaceuticals Recent Developments
  55. 8.10 Fredun Pharmaceuticals Ltd
  56. 8.10.1 Fredun Pharmaceuticals Ltd Company Information
  57. 8.10.2 Fredun Pharmaceuticals Ltd Business Overview
  58. 8.10.3 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Portfolio
  60. 8.10.5 Fredun Pharmaceuticals Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Albendazole Anthelmintic Drug Value Chain Analysis
  2. 9.1.1 Albendazole Anthelmintic Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Albendazole Anthelmintic Drug Sales Mode & Process
  6. 9.2 Albendazole Anthelmintic Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Albendazole Anthelmintic Drug Distributors
  9. 9.2.3 Albendazole Anthelmintic Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst